Literature DB >> 3818937

Presence of hepatitis B virus DNA in serum of surface-antigen-seronegative immunocompromised patients.

C C Pao, W L Yang, S Y Wu, G M Lai, L Y Shih, C F Sun, Y F Liaw.   

Abstract

We compared the prevalence of serum hepatitis B virus (HBV) DNA in cancer patients who were immunocompromised with that in healthy subjects. Testing positive for serum HBV DNA were 27 of the 232 (11.6%) surface-antigen-negative cancer patients and 7 of the 382 (1.8%) surface-antigen-negative healthy subjects. These data suggest that the negative serology, at least in immunocompromised individuals, is probably not sufficient to exclude HBV infection.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3818937      PMCID： PMC265923          DOI： 10.1128/jcm.25.2.449-451.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

Review 1.  Viral infections in immunocompromised patients.

Authors:  D T Wong; P L Ogra
Journal:  Med Clin North Am       Date:  1983-09       Impact factor: 5.456

2.  An assay for the detection of the DNA genome of hepatitis B virus in serum.

Authors:  M Berninger; M Hammer; B Hoyer; J L Gerin
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

3.  Histological evidence of hepatitis-B-virus infection with negative serology in children with acute leukaemia who develop chronic liver disease.

Authors:  D Vergani; A Locasciulli; G Masera; A Alberti; G Moroni; D E Tee; B Portmann; G Mieli Vergani; A L Eddleston
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

4.  Value of screening for markers of hepatitis in dialysis units.

Authors:  A J Ware; N L Gorder; L E Gurian; C Douglas; J W Shorey; T Parker
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

5.  Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.

Authors:  H M Lieberman; D R LaBrecque; M C Kew; S J Hadziyannis; D A Shafritz
Journal:  Hepatology       Date:  1983 May-Jun       Impact factor: 17.425
  5 in total
  1 in total

1.  Screening for hepatitis B virus in healthy blood donors by molecular DNA hybridization analysis.

Authors:  C F Sun; C C Pao; S Y Wu; Y F Liaw
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.